Zusammenfassung
Hintergrund
Konsiliarfälle des Jahres 2008, die der Überprüfung bzw. Konkretisierung der Primärdiagnose „Prostatakarzinom“ bzw. „suspekte Prostataläsion“ durch eine Zweitmeinung („second opinion“) dienten, wurden analysiert.
Material und Methodik
Histologische Schnittpräparate von 920 Stanzbiopsien wurden mit Hämatoxylin und Eosin gefärbt und ggf. immunhistochemisch mit verschiedenen Basalzellmarkern, dem Tumormarker α-Methylazyl-CoA-Razemase (P504 S), prostataspezifischem Antigen und neuroendokrinen Markern behandelt. Karzinome wurden nach dem modifizierten Gleason-Grading klassifiziert.
Ergebnisse
Die Zweitbegutachtung suspekter Prostatabefunde ergab in 43,5% der Fälle ein Adenokarzinom. In 53,2% wurden die atypische kleindrüsige Proliferation bestätigt und weitere Kontrollen empfohlen. Eine hochgradige prostatische intraepitheliale Neoplasie wurde nur 2-mal diagnostiziert. Der Verdacht auf ein Prostatakarzinom konnte in 87,2% gesichert werden. Nach Bestätigung mikrofokaler Karzinome lagen beim Grading in 82,8% Gleason-Scores 6 und 7(3 + 4) vor, die prognostisch der günstigen Low-grade-Gruppe zuzuordnen waren. High-grade-Karzinome machten in der Diagnostik und beim Grading keine Probleme.
Schlussfolgerungen
Die Zweitmeinung bei der histologischen Diagnostik von Prostataläsionen mit Verdacht auf Malignität dient der Qualitätssicherung bei der Prostatakarzinomdiagnostik und kann bei der Wahl der weiteren Therapie wegweisend sein.
Abstract
Objective
The significance of a second opinion on the histological findings of prostate carcinomas as well as suspicious lesions on core needle biopsy specimens was studied in cases from the year 2008.
Study design
A total of 920 core needle biopsy specimens of the prostate were stained with H & E and when necessary immunohistochemical analyses were performed with basal cell markers p63, 34ßE12, PSA and AMACR (P504 S) and neuroendocrine markers such as synaptophysin and chromogranin. The modified Gleason grading system was used.
Results
In 43.5% of suspicious lesions adenocarcinomas of the prostate were found. In 53.2% the findings of atypical small acinar proliferations or high-grade prostatic intraepithelial neoplasia (HGPIN) were confirmed with a recommendation of serum PSA and morphological controls. The suspicion of prostatic carcinoma could be confirmed in 87.2% by the diagnosis of adenocarcinoma. After Gleason grading 82.8% of all diagnosed carcinomas had scores 6 or 7(3 + 4) and belonged to the group of low grade carcinomas. High grade carcinomas were without diagnostic problems.
Conclusion
A second opinion on the histological analysis of suspicious lesions of the prostate as well as of confirmation of Gleason grading is a very important point of quality management of diagnostic steps of prostate carcinomas and may be helpful for different therapeutic strategies.
Literatur
Bishara T, Ramnani DM, Epstein JI (2004) High- grade prostatic intraepithelial neoplasia on needle biopsy. Risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 28:629–633
Brausi M, Castagnetti G, Dotti A et al (2004) Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? J Urol 172:906–908
Browne TJ, Hirsch MS, Brodsky G et al (2004) Prospective evaluation of AMACR (P504 S) and basal cell markers in the assessment of routine prostate needle bioopsy specimens. Hum Pathol 35:1462–1468
Chan TY, Epstein JI (1999) Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology 53:351–355
Dundore PA (1998) Atypical small acinar proliferations (ASAP) suspicious for malignancy in prostate needle biopsies. J Urol Pathol 8:21–29
Egevad L, Allsbrook WC, Epstein JI (2005) Current practice of Gleason grading among genitourinary pathologists. Hum Pathol 36:5–9
Epstein JI (1994) Diagnostic criteria of limited adenocarcinoma of the prostate of needle biopsy. Hum Pathol 26:223–229
Epstein JI (1998) Atypical small acinar proliferation of the prostate gland. Am J Surg Pathol 23:489–491
Epstein JI, Herawi M (2006) Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175:820–834
Epstein H, Algaba F, Allsbrook WC et al (2004) Acinar adenocarcinoma of the prostate. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) WHO classification of tumours IARC. Lyon, France, pp 179–184
Epstein JI, Allsbrook WC, Amin MB et al (2005) The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1227–1242
Halushka MK, KahaneH, Epstein JI (2004) Negative 34βE12 staining in a small focus of atypical glands on prostate needle biopsy: A follow-up study of 332 cases. Hum Pathol 35:43–46
Helpap B (1998) Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach. Virchows Arch 433:397–405
Helpap B, Oehler U, Köllermann J (1996) Erfahrungen aus dem Konsiliardienst für Prostaterkrankungen. Pathologe 17:417–424
Helpap B, Köllermann J, Oehler U (2001) Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry. J Pathol 193:350–353
Helpap B (2005) Kleine suspekte Prostataläsionen. Pathologe 26:398–404
Helpap B (2005) Problematik der pathologisch-histologischen Diagnostik beim Prostatakarzinom. Neue Tumormarker für mehr Sicherheit. Uro-News 6:31–43
Helpap B (2006) The significance of the P504 S expression pattern of the high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens. Virchows Arch 448:480–484
Helpap B, Egevad L (2006) The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch 449:622–627
Helpap B, Hartmann A, Wernert N (2011) Anleitung zur pathologisch-anatomischen Diagnostik von Prostatatumoren. BDP-Leitlinien, Bundesverband Deutscher Pathologen und Deutsche Gesellschaft für Pathologie (Hrsg)
Helpap B, Egevad L (2009) Modified Gleason grading. An updated review. Histol Histopathol 24:661–666
Helpap B, Köllermann J, Sauter G (2009) Modified Gleason grading and tumor extent in core needle biopsy specimens of prostatic carcinomas. Pathologe 30: Abstract Suppl 82
Helpap B, Kristiansen G, Beer M et al (2011) Die Bedeutung von fusionierten Drüsen beim Gleason Grading von Prostatakarzinomen. Pathologe 32: Abstr 112, Suppl 1:106
Hosler GA, Epstein JI (2005) Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies. Hum Pathol 36:480–485
Iczkowski KA, Ferguson KL, Grier DD et al (2003) Adenoid cystic/basal cell carcinoma of the prostate. Am J Surg Pathol 27:1523–1529
Jakse G, Kahl P, Luboldt H-J et al (2009) Pathomorphologische Untersuchungen. In: DGU (Hrsg) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Kap. 4.3, S 32–41
Kunju LP, Chinnaiyan AM, Shah RB (2005) Comparison of monoclonal antibody (P504 S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Histopathol 47:587–596
Lane Z, Epstein JI, Ajub S, Netto GJ (2008) Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features. Hum Pathol 39:543–549
Latour M, Amin MB, Billis A et al (2008) Grading of invasive cribriform carcinoma on prostate needle biopsy. Am J Surg Pathol 32:1532–1539
Lopez-Beltran A, Mikuz G, Luque RJ et al (2006) Current practice of Gleason grading of prostate carcinoma. Virchows Arch 448:111–118
Lotan TL, Epstein JI (2008) Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens. Am J Surg Pathol 32:1360–1366
Magi-Galuzzi C, Luo J, Isaacs WB et al (2003) Alpha-methylacyl-CoA racemase. A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 27:1128–1133
Montironi R, Scattoni V, Mazzucchelli R et al (2006) Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (Also referred to as „atypical small acinar proliferation suspicious for but not diagnostic of malignancy“). Eur Urol 50:666–674
Murphy WM (1999) ASAP is a bad idea. Hum Pathol 30:601
Osunkoya AO, Hansel DE, Sun X et al (2008) Abberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Am J Surg Pathol 32:461–467
Parwani AV, Kronz JD, Genega EM et al (2004) Prostate carcinoma with squamous differentiation. Am J Surg Pathol 28:651–657
Rasiah KK, Stricker PD, Haynes AM et al (2003) Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98:2560–2565
Scattoni V, Roscigno M, Freshi M et al (2005) Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl 77:31–36
Tavora F, Epstein JI (2008) High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: A clinipathologic study of 28 cases. Am J Surg Pathol 32:1060–1067
Van der Kwast TH, Evans A, Lockwood G et al (2010) Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol 34:169–177
Zareba P, Zhang J, Yilmaz A, Trpkov K (2009) The impact of the 2005 international society of urological pathology (ISUP) consensus on Gleason grading in contemorary practice. Histopathol 55:384–391
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Helpap, B., Oehler, U. Bedeutung der Zweitmeinung bei Prostatabiopsien. Pathologe 33, 103–112 (2012). https://doi.org/10.1007/s00292-011-1462-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-011-1462-y